Efficacy and Safety of Rituximab in Biologic-Naive Patients with Rheumatoid Arthritis vs Anti-Tnf Therapy Failure

OBJECTIVES: Our aim was to compare an AntiCD20 therapy (rituximab) for rheumatoid arthritis in two patient populations (Group 1), anti-TNFα naïve patients and inadequate responders to Anti-TNFα therapy (Group 2). METHODS: We analyzed the efficacy of the drug Rituximab (RTX) in RA patients who failed...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gutierrez-Gonzalez, Luis Arturo, Gudiño, Marco Antonio Rivera, Ceija, Ibell Oropeza, Leonet, Marialina Marin, Noguera, Zair Tovar
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Bentham Open 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3812784/
https://ncbi.nlm.nih.gov/pubmed/24179556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312920130913004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia